Xiao Zhiliang, Zhang Menglei, Shi Zhenduo, Zang Guanghui, Liang Qing, Hao Lin, Dong Yang, Pang Kun, Wang Yabin, Han Conghui
School of Medicine, Jiangsu University, Zhenjiang, China.
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
J Oncol. 2023 Mar 13;2023:4643792. doi: 10.1155/2023/4643792. eCollection 2023.
Clear cell renal cell carcinoma's (ccRCC) occurrence and development are strongly linked to the metabolic reprogramming of tumors, and thus far, neither its prognosis nor treatment has achieved satisfying clinical outcomes.
The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases, respectively, provided us with information on the RNA expression of ccRCC patients and their clinical data. Cuproptosis-related genes (CRGS) were discovered in recent massive research. With the help of log-rank testing and univariate Cox analysis, the prognostic significance of CRGS was examined. Different cuproptosis subtypes were identified using consensus clustering analysis, and GSVA was used to further investigate the likely signaling pathways between various subtypes. Univariate Cox, least absolute shrinkage and selection operator (Lasso), random forest (RF), and multivariate stepwise Cox regression analysis were used to build prognostic models. After that, the models were verified by means of the C index, Kaplan-Meier (K-M) survival curves, and time-dependent receiver operating characteristic (ROC) curves. The association between prognostic models and the tumor immune microenvironment as well as the relationship between prognostic models and immunotherapy were next examined using ssGSEA and TIDE analysis. Four online prediction websites-Mircode, MiRDB, MiRTarBase, and TargetScan-were used to build a lncRNA-miRNA-mRNA ceRNA network.
By consensus clustering, two subgroups of cuproptosis were identified that represented distinct prognostic and immunological microenvironments.
A prognostic risk model with 13 CR-lncRNAs was developed. The immune microenvironment and responsiveness to immunotherapy are substantially connected with the model, which may reliably predict the prognosis of patients with ccRCC.
透明细胞肾细胞癌(ccRCC)的发生和发展与肿瘤的代谢重编程密切相关,迄今为止,其预后和治疗均未取得令人满意的临床结果。
癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)分别为我们提供了ccRCC患者的RNA表达信息及其临床数据。铜死亡相关基因(CRGS)是在最近的大量研究中发现的。借助对数秩检验和单变量Cox分析,研究了CRGS的预后意义。使用一致性聚类分析确定不同的铜死亡亚型,并使用基因集变异分析(GSVA)进一步研究不同亚型之间可能的信号通路。使用单变量Cox、最小绝对收缩和选择算子(Lasso)、随机森林(RF)和多变量逐步Cox回归分析来构建预后模型。之后,通过C指数、Kaplan-Meier(K-M)生存曲线和时间依赖性受试者工作特征(ROC)曲线对模型进行验证。接下来,使用单样本基因集富集分析(ssGSEA)和肿瘤免疫功能障碍和排除分析(TIDE)来研究预后模型与肿瘤免疫微环境之间的关联以及预后模型与免疫治疗之间的关系。使用四个在线预测网站——Mircode、MiRDB、MiRTarBase和TargetScan——构建lncRNA-miRNA-mRNA竞争性内源性RNA(ceRNA)网络。
通过一致性聚类,确定了两个铜死亡亚组,它们代表了不同的预后和免疫微环境。
建立了一个包含13个铜死亡相关长链非编码RNA(CR-lncRNAs)的预后风险模型。该模型与免疫微环境和免疫治疗反应性密切相关,可能可靠地预测ccRCC患者的预后。